Skip to main content

Table 1 Development of Enterobacteriaceae resistance to selected antibiotics in the UHO in 2000–2011 (in percentages)

From: Antibiotic consumption and its influence on the resistance in Enterobacteriaceae

  

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

CPR

KLPN

18

22

19

14

14

16

11

20

42

39

41

41

 

ESCO

4

4

2

2

2

3

4

10

11

12

12

11

 

ENCL

15

18

22

21

24

15

15

22

30

23

35

32

 

PRMI

4

6

2

2

2

2

2

2

2

2

2

2

CTX

KLPN

5

7

6

5

11

12

8

14

38

37

39

40

 

ESCO

1

1

1

1

1

1

2

7

9

11

11

10

 

ENCL

10

18

23

23

24

18

17

24

29

23

35

32

 

PRMI

1

1

1

1

0

1

1

0

0

1

1

1

CTZ

KLPN

5

7

6

7

12

17

24

24

42

37

40

40

 

ESCO

1

1

1

1

2

2

3

8

10

11

11

10

 

ENCL

6

18

23

26

24

19

17

26

30

23

35

32

 

PRMI

2

1

1

0

1

0

0

1

0

1

1

1

CPM

KLPN

NT

5

4

3

4

3

2

11

34

30

36

36

 

ESCO

NT

1

0

0

1

0

1

6

8

10

10

9

 

ENCL

NT

8

5

1

4

1

2

2

6

8

5

13

 

PRMI

NT

1

1

0

0

1

0

0

0

1

0

0

MER

KLPN

0

0

0

0

1

1

0

0

0

0

0

1

 

ESCO

0

0

0

0

0

0

1

1

0

0

0

0

 

ENCL

0

3

0

2

0

2

1

1

1

1

0

0

 

PRMI

0

0

1

0

0

0

1

0

0

0

0

0

PPT

KLPN

12

19

13

10

11

12

23

31

41

40

43

42

 

ESCO

1

2

2

2

2

2

3

9

9

12

12

11

 

ENCL

7

13

27

17

16

10

9

20

29

23

35

33

 

PRMI

2

1

1

1

1

1

1

1

1

1

1

1

OFL

KLPN

6

8

15

10

10

11

29

28

30

36

38

41

 

ESCO

3

5

5

8

10

13

15

19

22

21

23

21

 

ENCL

3

6

5

2

3

4

3

6

7

6

15

10

 

PRMI

11

14

14

17

19

17

22

29

33

34

35

33

CIP

KLPN

5

10

17

13

10

13

31

30

46

40

42

44

 

ESCO

4

6

6

10

11

14

17

22

26

23

26

23

 

ENCL

2

6

5

1

4

4

2

7

9

6

17

11

 

PRMI

7

16

17

20

18

16

23

29

36

37

39

36

GEN

KLPN

12

15

17

17

19

17

17

18

35

32

37

37

 

ESCO

3

4

4

4

5

7

6

8

9

8

8

7

 

ENCL

15

5

0

4

2

4

1

5

8

4

6

15

 

PRMI

48

39

30

23

22

21

18

17

19

21

20

20

AMI

KLPN

2

6

7

5

3

8

4

5

12

8

12

8

 

ESCO

1

1

1

0

0

0

1

2

2

2

5

4

 

ENCL

2

2

1

1

0

0

1

2

2

2

2

2

 

PRMI

2

5

4

2

2

1

1

2

5

2

3

1

  1. Legend: CPR - cefoperazone, CTX - cefotaxime, CTZ - ceftazidime, CPM - cefepime, MER - meropenem, PPT - piperacillin/tazobactam, OFL - ofloxacin, CIP - ciprofloxacin, GEN - gentamicin, AMI - amikacin, KLPN - Klebsiella pneumoniae, ESCO - Escherichia coli, ENCL - Enterobacter cloacae, PRMI - Proteus mirabilis, NT - not tested.
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us